New melanoma drug gets Medsafe registration for lung cancer

Short resume:

cancer
90%
zealand
60%
keytruda
60%
melanoma
60%

Keytruda is an immunotherapy drug used to treat advanced melanoma and, more recently, lung cancer. A new drug which was recently funded for melanoma treatment is now registered for lung cancer treatment in New Zealand.
Source Stuff.co.nz
Read More…

More News

Be the first to comment

Leave a Reply

Your email address will not be published.


*